<?xml version="1.0" encoding="UTF-8"?>
<ref id="C234">
 <label>234</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Shiraki</surname>
    <given-names>K</given-names>
   </name>, 
   <name name-style="western">
    <surname>Daikoku</surname>
    <given-names>T</given-names>
   </name>
  </person-group>
  <article-title>Favipiravir, an anti-influenza drug against life-threatening RNA virus infections</article-title>. 
  <source>Pharmacol Ther</source>
  <year>2020</year>; 
  <volume>209</volume>: 
  <fpage>107512</fpage>. doi:
  <pub-id pub-id-type="doi">10.1016/j.pharmthera.2020.107512</pub-id>
  <pub-id pub-id-type="pmid">32097670</pub-id>
 </mixed-citation>
</ref>
